genworth financial inc. - GNW
GNW
Close Chg Chg %
7.63 0.14 1.84%
Closed Market
7.77
+0.14 (1.84%)
Volume: 3.53M
Last Updated:
Nov 22, 2024, 3:59 PM EDT
Company Overview: genworth financial inc. - GNW
GNW Key Data
| Open $7.65 | Day Range 7.65 - 7.77 |
| 52 Week Range 5.67 - 7.77 | Market Cap $3.25B |
| Shares Outstanding 427.03M | Public Float 418.58M |
| Beta 0.95 | Rev. Per Employee N/A |
| P/E Ratio 37.28 | EPS $0.21 |
| Yield 0.00% | Dividend $0.10 |
| EX-DIVIDEND DATE Oct 8, 2008 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.80M |
GNW Performance
| 1 Week | 5.71% | ||
| 1 Month | 15.28% | ||
| 3 Months | 13.93% | ||
| 1 Year | 31.92% | ||
| 5 Years | 91.38% |
GNW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 7.50 | |
| Number of Ratings | 2 | Current Quarters Estimate | 0.22 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 0.835 | |
| Last Quarter’s Earnings | 0.11 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.09 | Next Fiscal Year Estimate | 0.90 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | N/A | 2 | 2 |
| Mean Estimate | 0.22 | N/A | 0.84 | 0.90 |
| High Estimates | 0.22 | N/A | 0.95 | 1.10 |
| Low Estimate | 0.22 | N/A | 0.72 | 0.70 |
| Coefficient of Variance | N/A | N/A | 19.48 | 31.43 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 0 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 2 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Genworth Financial Inc. - GNW
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Genworth Financial Inc. - GNW
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 29, 2024 | Robert P. Restrepo Director | 100,710 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 648,572.40 |
| May 29, 2024 | G. Kent Conrad Director | 50,710 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 326,572.40 |
| May 29, 2024 | Karen E. Dyson Director | 50,710 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 326,572.40 |
| May 29, 2024 | Howard D. Mills Director | 50,710 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 326,572.40 |
| May 29, 2024 | Ramsey D. Smith Director | 50,710 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 326,572.40 |
| May 29, 2024 | Jill Rebecca Goodman Director | 50,710 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 326,572.40 |
| May 29, 2024 | Elaine Ann Sarsynski Director | 91,277 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 587,823.88 |
| May 29, 2024 | Thomas J. McInerney President and CEO; Director; Director | 4,211,980 | Bona fide gift | 0.00 |
| May 29, 2024 | Thomas J. McInerney President and CEO; Director; Director | 4,361,980 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $6.27 per share | 27,349,614.60 |
| May 29, 2024 | Melina E. Higgins Director | 91,277 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $6.44 per share | 587,823.88 |
| Mar 6, 2024 | Jerome T. Upton EVP & Chief Financial Officer | 384,852 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2024 | Jerome T. Upton EVP & Chief Financial Officer | 322,167 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.15 per share | 1,981,327.05 |
| Mar 6, 2024 | Andrea Lynn White EVP-CareScout Insurance | 666,802 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2024 | Rohit Gupta President & CEO, Enact | 821,956 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.15 per share | 5,055,029.40 |
| Mar 6, 2024 | Gregory S. Karawan EVP and General Counsel | 293,617 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2024 | Gregory S. Karawan EVP and General Counsel | 248,589 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.15 per share | 1,528,822.35 |
| Mar 6, 2024 | Rohit Gupta President & CEO, Enact | 1,088,364 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2024 | Andrea Lynn White EVP-CareScout Insurance | 570,315 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.15 per share | 3,507,437.25 |
| Feb 28, 2024 | Darren W. Woodell VP and Controller | 25,652 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 28, 2024 | Mark Blakeley Hodges EVP and Chief Risk Officer | 65,147 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |